Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
easily detect tumor risks in the early stages. With 2 milliliters of blood, cancer differentiation analysis technology can detect more than 10 different types of cancer in all stages of development
mRNA-based cancer immunotherapy. “This transaction is another building block in BioNTech’s oncology strategy and an investment in the future of cancer medicine,” said Ugur Sahin, CEO and co-founder of
Blincyto infringed Lindis patents related to reducing the side effects of using "bispecific" antibodies to stimulate the body's immune system to kill cancer cells. Amgen denied the allegations and
total 1 pages, 3 items
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
